Get started
Author

Hilario J. Ramos

Observed names: Hilario J Ramos, Hilario Jose Ramos, Hilario Ramos, Hilario J. Ramos
ORCID: 0000-0003-3958-2725
Observed ORCID: 0000-0003-3958-2725
OpenAlex ID: A5005113342
IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
2013 · Amina A. Negash, Hilario J. Ramos, et al. · PLoS Pathogens · 415
PDF
IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection
2012 · Hilario J. Ramos, Marion C. Lanteri, et al. · PLoS Pathogens · 240
PDF
RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity
2011 · Hilario J Ramos, Michael Gale · Current Opinion in Virology · 200
The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection
2017 · Congrong Niu, Christine M. Livingston, et al. · PLoS ONE · 150
PDF
Cutting Edge: Type I IFN Reverses Human Th2 Commitment and Stability by Suppressing GATA3
2010 · Jonathan P Huber, Hilario J Ramos, et al. · The Journal of Immunology · 140
The RIG-I-like Receptor LGP2 Controls CD8+ T Cell Survival and Fitness
2012 · Mehul S. Suthar, Hilario J. Ramos, et al. · Immunity · 126
PDF
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism
2017 · Congrong Niu, Li Li, et al. · Journal of Hepatology · 99
A Systems Biology Approach Reveals that Tissue Tropism to West Nile Virus Is Regulated by Antiviral Genes and Innate Immune Cellular Processes
2013 · Mehul S. Suthar, Margaret M. Brassil, et al. · PLoS Pathogens · 88
PDF
Reciprocal responsiveness to interleukin-12 and interferon-α specifies human CD8+ effector versus central memory T-cell fates
2009 · Hilario J. Ramos, Ann M. Davis, et al. · Blood · 74
Deficient IFN Signaling by Myeloid Cells Leads to MAVS-Dependent Virus-Induced Sepsis
2014 · Amelia K. Pinto, Hilario J. Ramos, et al. · PLoS Pathogens · 68
PDF
IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo
2011 · Fatema Z. Chowdhury, Hilario J. Ramos, et al. · Blood · 68
Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses
2018 · Lauren D. Aarreberg, Courtney Wilkins, et al. · mBio · 63
Pattern Recognition Receptor MDA5 Modulates CD8 + T Cell-Dependent Clearance of West Nile Virus from the Central Nervous System
2013 · Helen M. Lazear, Amelia K. Pinto, et al. · Journal of Virology · 61
PDF
IFN-α Is Not Sufficient to Drive Th1 Development Due to Lack of Stable T-bet Expression
2007 · Hilario J Ramos, Ann M Davis, et al. · The Journal of Immunology · 49
PDF
Cutting Edge: A T-bet-Independent Role for IFN-α/β in Regulating IL-2 Secretion in Human CD4+ Central Memory T Cells
2008 · Ann M Davis, Hilario J Ramos, et al. · The Journal of Immunology · 30
PDF
The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
2022 · Michelle H. Nelson, Sara Fritzell, et al. · Molecular Cancer Therapeutics · 11
SAT-536 Uptake and T cell stimulation by anti-HBs monoclonal antibody BJT-778-rHBsAg immune complexes
2024 · Loghman Salimzadeh, Stuti Shah, et al. · Journal of Hepatology · 3
500 INV322, a TME selective CD25 x CTLA4 bispecific antibody approach for depletion of tumor restricted Tregs
2022 · Anna Ritter, Nicholas Marshal, et al. · Regular and Young Investigator Award Abstracts · 3
PDF
Abstract 3366: In vivo efficacy of a PD-L1 targeted, antigen seeding engineered toxin body
2020 · Hilario J. Ramos, Brigitte Brieschke, et al. · Cancer Research · 3
WED-366 Characterization of BJT-778, an anti-HBsAg neutralizing monoclonal antibody for treatment of hepatitis B virus and hepatitis D virus infections
2024 · Hilario Ramos, Ronald Alcala, et al. · Journal of Hepatology · 2
Abstract 3434: APVO442 is a distinct PSMA x CD3 targeted bispecific candidate designed to optimize T cell fitness and distribution to solid tumors
2022 · Rebecca Gottschalk, Robert Miller, et al. · Cancer Research · 2
Abstract 1628: Engineered toxin bodies targeting PD-L1 to alter tumor immunophenotypes and deliver broad antigenic diversity and patient coverage
2021 · Joseph D. Dekker, Swati Khanna, et al. · Cancer Research · 2
Prediction of immunotherapy response using live tumor fragments from routine clinical biopsies
2026 · David Braun, Nicholas Dana, et al. · medRxiv · 1
Abstract 539: Novel engineered toxin bodies targeting SLAMF7 (CS1)
2020 · Aimee Iberg, Garrett L. Cornelison, et al. · Cancer Research · 1
PD-L1 targeted engineered toxin body provides direct cytotoxicity and T-cell mediated tumor targeting.
2020 · Roger J. Waltzman, Brigitte Brieschke, et al. · Journal of Clinical Oncology · 1
Works count: 64
Citation count: 1,901
H-index: 15
I10-index: 16
Year
Topic
Type